Last reviewed · How we verify
NCT05402631
Can Patient Expectations Influence Pain Reduction After Epidural Injections in Patients With Low Back Pain?
trial testing Epidural Injection in Expectations in 80 participants. Status unknown.
30 September 2022
Quick facts
| Lead sponsor | Ospedale Regionale di Lugano |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 20 April 2022 |
| Primary completion | 30 September 2022 |
| Estimated completion | 30 September 2022 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Epidural Injection — full drug profile →
- Periradicular Injection
Conditions studied
- Expectations — all drugs for Expectations →
- Back Pain — all drugs for Back Pain →
- Back Pain Lower Back Chronic — all drugs for Back Pain Lower Back Chronic →
- Satisfaction, Patient — all drugs for Satisfaction, Patient →
Sponsor
Ospedale Regionale di Lugano
Who can join
18 and older, any sex, with Expectations or Back Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Investigators hypothesize that patients with higher expectations regarding their epidural injection experience a higher pain reduction of their lower back pain and/or leg pain after an epidural injection. Patients' expectations of an epidural injection can influence their level of pain reduction. The primary objective of this study is to investigate the prognostic significance of patient expectations on pain reduction after epidural injections ('expected benefits', see under) in patients with low back pain and/or leg pain. Investigators furthermore hypothesize that patients that have a higher match between their expectations of improvement and actual improvement are more satisfied. A secondary objective of this study is to investigate the prognostic significance of a high match between expectations of improvement and actual improvement on patient satisfaction of the treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05402631
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Epidural Injection
Trials testing the same drug.
- NCT07370233 — Triple Therapy Strategy for Managing Persistent Pain After Spinal Microdiscectomy · Phase 2 · completed
Other recruiting trials for Expectations
Currently open trials in the same condition.
- NCT06980090 — Neural Mechanisms of Interpersonal Expectations on Negative Affect · NA · recruiting
- NCT06080997 — Patients' Expectations Before Spinal Surgery · recruiting
- NCT05191277 — Disentangling Pharmacological and Expectation Effects in Antidepressant Discontinuation · NA · active not recruiting
- NCT05733039 — Association of Expectations and Pain Relief After Diagnostic Nerve Blocks · active not recruiting
Other Ospedale Regionale di Lugano trials
Trials by the same sponsor.
- NCT05949970 — The Lumbar Trident Study · completed
- NCT05353465 — The Cervical Trident Study · completed
- NCT04490616 — TMS Treatment of Social Cognition Skills in Mild Cognitive Impairment · NA · completed
- NCT04582721 — PREFerred Neurostimulation MODdalities - PREFMOD Study · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05402631 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ospedale Regionale di Lugano
- Last refreshed: 3 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05402631.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing